Elucidation of the Mechanisms for Glutamate Release in Ischemic Neuronal Injury

阐明缺血性神经元损伤中谷氨酸释放的机制

基本信息

  • 批准号:
    11470283
  • 负责人:
  • 金额:
    $ 9.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Elucidation of the Mechanisms for Glutamate Release in Ischemic Neuronal InjuryThere have been an accumulating evidence that extracellular glutamate is contineously taken up and regulated in concentration by glutamate transporters. Especially, GLT-1 is specifically and widely distributed in forebrain area. Recently, GLT-1 has reported to release intracellular glutamate toward extracellular space in a condition such as ischemia.To test this hypothesis and make sure the function of GLT-1 during ischemia, we determined extracellular glutamate concentration in gerbils with naive and ischemic condition by inhibition of glutamate transporter. In addition, we produced a focal cerebral ischemia by cauterization of the middle cerebral artery in mice with GLT-1 gene deleted and its wild type.Results :(1) We infused tPDC, an inhibitor of a glutamate transporter and collected extracellular fluid of gerbil brain by a microdialysis method. We confirmed that extracellular glutamate increased during an inhibition of a glutamate transporter. This result indicates that a glutamate transporter plays an important role in regulating extracellular glutamate concentration. As the next step, we induced a transient global ischemia to gerbils which were pre-infused with tPDC.We could not confirm the significant protective effect against neurons in CA1 sector of the hippocampus of the animals.(2) We used GLT-1 gene knockout mice to examine whether ischemic neuronal death is accelerated and an infarct size is augmented. By producing a permanent focal cerebral ischemia, there was no differences in infarct volumes (homozygotes : 12.6±10.3, wild type : 12.6±6.8, Mean±SD mm^3). Since there is a possibility that the severity of an initial ischemic insult but not glutamate toxicity affected the neuronal cell death, we are ongoing to measure the infarct volumes by adopting ischemia-reperfusion models which are less severe than permanent ischemia.
缺血性神经元损伤中谷氨酸释放机制的研究越来越多的证据表明,细胞外谷氨酸被谷氨酸转运体持续摄取并调节其浓度。尤其是GLT-1在前脑区特异而广泛的分布。近年来,GLT-1在缺血等条件下向细胞外释放谷氨酸,为了验证这一假设并确定GLT-1在缺血过程中的功能,我们通过抑制谷氨酸转运体的方法测定了沙土鼠在初始和缺血条件下细胞外谷氨酸的浓度。结果:(1)灌胃谷氨酸转运体抑制剂tPDC,用微透析法收集沙土鼠脑细胞外液。我们证实,细胞外谷氨酸增加谷氨酸转运蛋白抑制期间。这一结果表明谷氨酸转运蛋白在调节细胞外谷氨酸浓度方面发挥着重要作用。下一步,我们诱导沙土鼠短暂性全脑缺血,预先注入tPDC,我们不能证实对动物海马CA 1区的神经元有明显的保护作用。(2)我们使用GLT-1基因敲除小鼠来检查缺血性神经元死亡是否加速和梗死面积是否增加。通过产生永久性局灶性脑缺血,梗死体积没有差异(纯合子:12.6±10.3,野生型:12.6±6.8,平均值±标准差mm^3)。由于存在初始缺血损伤的严重性而非谷氨酸毒性影响神经元细胞死亡的可能性,因此我们正在通过采用比永久性缺血更轻的缺血-再灌注模型来测量梗死体积。

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawahara N, Mishima K, Higashiyama S, Taniguchi N, Tamura A and Kirino T: "The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible : its role in cerebral ischemia."J Cereb Blood Flow Metab. 19. 307-320 (1999)
Kawahara N、Mishima K、Higashiyama S、Taniguchi N、Tamura A 和 Kirino T:“肝素结合表皮生长因子样生长因子的基因是应激诱导的:其在脑缺血中的作用。”J Cereb Blood Flow Metab。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawai K, KAwahara N, Saito N, Nakatomi H, Ichi S and Kirino T: "Effect of selective blocker of Ca2+-permeable AMPA receptor in gerbil forebrain ischemia : In vivo verification of GluR2 hypothesis in delayed neuronal death of CA1 neurons."J Cereb Blood Flo
Kawai K、KAwahara N、Saito N、Nakatomi H、Ichi S 和 Kirino T:“Ca2 渗透性 AMPA 受体选择性阻断剂对沙鼠前脑缺血的影响:体内验证 GluR2 假设在 CA1 神经元延迟性死亡中的作用。”J
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawai K,Kawahara N,Saito N,Nakatomi H,Ichi S,Kirino T: "Effect of selective blocker of Ca^<2+>-permeable AMPA receptor in gerbil forebrain ischemia : In vivo verification of GluR2 hypothesis in delayed neuronal death of CA1 neurons"J Cereb Blood Flow Meta
Kawai K、Kawahara N、Saito N、Nakatomi H、Ichi S、Kirino T:“Ca^<2>-渗透性 AMPA 受体选择性阻断剂对沙鼠前脑缺血的影响:GluR2 假说在 CA1 延迟性神经元死亡中的体内验证
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawahara N,Mishima K,Higasa S,Taniguchi N,Tamura A and Kirino T: "The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible : its role in cerebral ischemia."J Cereb Blood Flow Metab. 19. 307-320 (1999)
Kawahara N、Mishima K、Higasa S、Taniguchi N、Tamura A 和 Kirino T:“肝素结合表皮生长因子样生长因子的基因是应激诱导的:其在脑缺血中的作用。”J Cereb Blood Flow Metab。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawai K,Kawahara N,Saito N,Nakatomi H,Ichi S and Kirino T: "Effect of selective blocker of Ca2+-permeable AMPA receptor in gerbil forbrain ischemia : In vivo verifyication of GluR2 hypothesis in delayed neuronal death of CA1 neurons."J Cereb Blood Flow Me
Kawai K、Kawahara N、Saito N、Nakatomi H、Ichi S 和 Kirino T:“Ca2 渗透性 AMPA 受体选择性阻断剂对沙鼠前脑缺血的影响:体内验证 GluR2 假设在 CA1 神经元延迟性神经元死亡中的作用。”J
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIRINO Takaaki其他文献

KIRINO Takaaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIRINO Takaaki', 18)}}的其他基金

Genome-wide expression analysis of ischemic neuronal injury based on functional genomics and proteomics
基于功能基因组学和蛋白质组学的缺血性神经元损伤的全基因组表达分析
  • 批准号:
    13307042
  • 财政年份:
    2001
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The role of ubiquitin in neuronal apoptosis
泛素在神经细胞凋亡中的作用
  • 批准号:
    09470290
  • 财政年份:
    1997
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Stress Response in Cerebral Ischemia and the Role of Ubiquitin
脑缺血的应激反应和泛素的作用
  • 批准号:
    07457305
  • 财政年份:
    1995
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of Neuronal Cell Death following Cerebral Ischemia
脑缺血后神经细胞死亡的机制
  • 批准号:
    05404049
  • 财政年份:
    1993
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Trarable ischemic neuronal damage
可治疗的缺血性神经元损伤
  • 批准号:
    61570706
  • 财政年份:
    1986
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Regulatory mechanism of ferroptosis via cystine/glutamate transporter regulated by food derived ingredients
食品衍生成分通过胱氨酸/谷氨酸转运蛋白调节铁死亡的调节机制
  • 批准号:
    23KK0109
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Dual-function glutamate transporter/chloride channels in brain physiology and neurological diseases.
脑生理学和神经系统疾病中的双功能谷氨酸转运蛋白/氯离子通道。
  • 批准号:
    480399
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Operating Grants
Dysregulation of glutamate transporter-dependent neurovascular coupling in Alzheimer's disease
阿尔茨海默病中谷氨酸转运蛋白依赖性神经血管耦合的失调
  • 批准号:
    10657894
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain
对健康和阿尔茨海默病大脑中星形细胞谷氨酸转运蛋白 (EAAT2) PET 示踪剂的首次人体评估
  • 批准号:
    10683344
  • 财政年份:
    2022
  • 资助金额:
    $ 9.47万
  • 项目类别:
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain
对健康和阿尔茨海默病大脑中星形细胞谷氨酸转运蛋白 (EAAT2) PET 示踪剂的首次人体评估
  • 批准号:
    10539917
  • 财政年份:
    2022
  • 资助金额:
    $ 9.47万
  • 项目类别:
Astrocytic Glutamate Transporter 1 (GLT-1) enhancement for the treatment of seizures in Dravet Syndrome
星形细胞谷氨酸转运蛋白 1 (GLT-1) 增强治疗 Dravet 综合征癫痫发作
  • 批准号:
    10288936
  • 财政年份:
    2021
  • 资助金额:
    $ 9.47万
  • 项目类别:
Elucidation of the potential role of the cystine/glutamate transporter in the regulation of tumor metastasis through interaction with integrin
阐明胱氨酸/谷氨酸转运蛋白通过与整合素相互作用调节肿瘤转移的潜在作用
  • 批准号:
    21K15481
  • 财政年份:
    2021
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of Glutamate Transporter Imaging Agents for Detection of Neurodegenerative Diseases of the Brain
开发用于检测大脑神经退行性疾病的谷氨酸转运蛋白成像剂
  • 批准号:
    17K10357
  • 财政年份:
    2017
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of cystine/glutamate transporter in cancer metastasis.
胱氨酸/谷氨酸转运蛋白在癌症转移中的作用。
  • 批准号:
    17K07158
  • 财政年份:
    2017
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of small molecule activators of glutamate transporter EAAT2 for treatment of Alzheimer's disease
开发用于治疗阿尔茨海默病的谷氨酸转运蛋白 EAAT2 小分子激活剂
  • 批准号:
    9752404
  • 财政年份:
    2017
  • 资助金额:
    $ 9.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了